Atlas Trials

Myeloproliferative Diseases

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myeloproliferative Diseases

RecordFirmDate
Investigation of the Genetics of Hematologic Diseases (NCT02720679)St. Jude Children's Research Hospital2016-06-17
Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN) (NCT02410551)M.D. Anderson Cancer Center2015-06-15
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF) (NCT02267278)M.D. Anderson Cancer Center2015-01-12
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene (NCT01875237)M.D. Anderson Cancer Center2013-12-27
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning (NCT01572662)M.D. Anderson Cancer Center2012-04-11
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) (NCT01518153)M.D. Anderson Cancer Center2012-02-01
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) (NCT01444742)M.D. Anderson Cancer Center2011-11-16
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis (NCT01375140)M.D. Anderson Cancer Center2011-09-22
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases (NCT00606307)Italfarmaco2007-12-01
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia (NCT00513175)University of California, San Francisco2001-10-01

Track Myeloproliferative Diseases automatically

Every clearance here is in the API, with alerts when new ones post.